Haifeng Lin

630 citations
32 papers · 303 indexed · h-index 8
Topics
Lung Cancer Diagnosis and Treatment (8 papers)Lung Cancer Research Studies (7 papers)Lung Cancer Treatments and Mutations (6 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaAnnals of Oncology
Partner nations
ChinaMongoliaGreece

In The Last Decade

Haifeng Lin

31 papers receiving 301 citations

Peers

Haifeng Lin
Comparison fields: 5 of 58
  • Oncology 108
  • Molecular Biology 98
  • Cancer Research 70
  • Pulmonary and Respiratory Medicine 55
  • Epidemiology 53
Replace Yuqiang Shan with:
Yuqiang Shan China
Yingwei Zhu China
Hong Yuan China
Xianhai Mao China
Marie Pierre Chenard France
Rongce Zhao China
Xuexiu Zhang China
Marion L. Hartley United States
Mushtaq Ashraf Pakistan
Haifeng Lin relative to Yuqiang Shan China Yuqiang Shan's profile →
Citations per field
00.5×1.5×
Yuqiang Shan · 1×
Citations per year

Countries citing papers authored by Haifeng Lin

Since Specialization
Citations

This map shows the geographic impact of Haifeng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haifeng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haifeng Lin more than expected).

Fields of papers citing papers by Haifeng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haifeng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haifeng Lin. The network helps show where Haifeng Lin may publish in the future.

Co-authorship network of co-authors of Haifeng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Haifeng Lin. A scholar is included among the top collaborators of Haifeng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haifeng Lin. Haifeng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 3
4 0
5 14
6 4
7 2
8 10
9 3
10 152
11 5
12 6
13 5
14 7
15 13
16 6
17 14
18 8
19 5
20 1

About Haifeng Lin

Haifeng Lin is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 303 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Research Studies (7 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Hepatology (50 citations), Cancer Research (70 citations) and Oncology (108 citations). Haifeng Lin has collaborated with scholars based in China, Mongolia and Greece. Frequent co-authors include Mingyue Zhu, Mengsen Li, Haiqing Zhang, Yang Qu, Kun Li, Zhiming Zeng, Chengsheng Zhang, Chen Zhang, Li‐Hua Yang and Xiaohong Zhuang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026